These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 214608

  • 1. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF.
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract] [Full Text] [Related]

  • 2. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. I. Cell requirements, specificity, lack of H-2 restriction, and role of antibody.
    Mortensen RF, Elson LM.
    J Immunol; 1980 May; 124(5):2316-23. PubMed ID: 6154099
    [No Abstract] [Full Text] [Related]

  • 5. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F, Jongeneel CV.
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antigenic properties of a nonreleaser neoplasm induced in the mouse by murine sarcoma virus.
    Law LW, Ting RC.
    J Natl Cancer Inst; 1970 Mar; 44(3):615-21. PubMed ID: 11515430
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
    Takeichi N, Austin FC, Oikawa T, Boone CW.
    Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours.
    Gomard E, Duprez V, Henin Y, Levy JP.
    J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802
    [Abstract] [Full Text] [Related]

  • 18. [Studies on column fractionation of immune cells. 3. Tumor neutralization test].
    Eckert R, Pasternak G.
    Acta Biol Med Ger; 1973 Feb; 31(2):305-10. PubMed ID: 4544039
    [No Abstract] [Full Text] [Related]

  • 19. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.